VivoSim Labs (VIVS) Depreciation & Amortization (CF) (2011 - 2026)
VivoSim Labs (VIVS) posted Depreciation & Amortization (CF) of $40000.0 for Q2 2026, down 6.98% on a QoQ basis from $43000.0 in Q1 2026, and down 34.43% year-over-year from $61000.0 in Q2 2025.
Powered by 
Analysis
VivoSim Labs (VIVS) Depreciation & Amortization (CF) (2011 - 2026) Analysis & Trends
VivoSim Labs has reported Depreciation & Amortization (CF) for 16 years, with the latest figure at $40000.0 in Q2 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 34.43% year-over-year to $40000.0 in Q2 2026; TTM through Jun 2026 was $194000.0, a 24.51% decrease from a year earlier, with the FY2026 full-year figure at $215000.0, down 19.17% from the prior year.
- Depreciation & Amortization (CF) was $40000.0 for Q2 2026 at VivoSim Labs, down from $43000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $130000.0 in Q4 2022, with the low at $40000.0 in Q2 2026.
- Average Depreciation & Amortization (CF) over 5 years is $63333.3, with a median of $61000.0 recorded in 2025.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) soared 251.35% in 2022, then plunged 45.38% in 2023.
- Over 5 years, Depreciation & Amortization (CF) stood at $130000.0 in 2022, then slumped by 45.38% to $71000.0 in 2023, then declined by 5.63% to $67000.0 in 2024, then fell by 22.39% to $52000.0 in 2025, then slipped by 23.08% to $40000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $40000.0 (Q2 2026), $43000.0 (Q1 2026), and $52000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 292.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 90.77 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 67.29 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 19.60 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 12.32 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 314,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 190,775.50 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 40,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40,000.00 |
| Mar 31, 2026 | 43,000.00 |
| Dec 31, 2025 | 52,000.00 |
| Sep 30, 2025 | 59,000.00 |
| Jun 30, 2025 | 61,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Dec 31, 2024 | 67,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Jun 30, 2024 | 70,000.00 |
| Mar 31, 2024 | 71,000.00 |
| Dec 31, 2023 | 71,000.00 |
| Sep 30, 2023 | 71,000.00 |
| Jun 30, 2023 | 67,000.00 |
| Mar 31, 2023 | 59,000.00 |
| Dec 31, 2022 | 130,000.00 |
| Sep 30, 2022 | 54,000.00 |
| Jun 30, 2022 | 50,000.00 |
| Mar 31, 2022 | 46,000.00 |
| Dec 31, 2021 | 37,000.00 |
| Sep 30, 2021 | 34,000.00 |